Comparison of two routes of injection of MMR vaccine in the treatment of multiple warts
Not Applicable
- Conditions
- Health Condition 1: null- multiple verruca vulgaris
- Registration Number
- CTRI/2018/02/012128
- Lead Sponsor
- Indian association of Dermatologists Venereologists and leprologists West Bengal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male or female patients between 18 and 65 years of age (both inclusive).
ii.Multiple viral warts >= 2 including genital warts
iii.Patients who give their informed consent.
iv.Patients not having received any anti-wart treatment in the past 4 weeks
iv. Lack of viral diseases such as herpes and/or bacterial infections such as impetigo
Exclusion Criteria
Pregnant and lactating women.
ii.Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid or other non-steroidal immunosuppressive drug use etc.).
iii.Any other systemic disease (eg. liver or kidney disorder).
iv. Presence of ulcerated or inflamed wart(s).
vi.Patients who participated in a clinical trial in the last 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction in number and size of wartsTimepoint: at 4, 8 and 16 weeks
- Secondary Outcome Measures
Name Time Method side effects of the two routes of vaccine.Timepoint: immediate and again at at 4,8 and 16 weeks